Loading…

Loading grant details…

Completed H2020 European Commission

Therapeutic molecules and druggable sites to suppress aberrant ion channel activity in cancer.

€275.2K EUR

Funder European Commission
Recipient Organization Universita Degli Studi Di Pavia
Country Italy
Start Date Oct 01, 2021
End Date Sep 30, 2024
Duration 1,095 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 101030017
Grant Description

TASK-3 is a potassium channel member of the recently discovered two-pore potassium channels family (K2P) responsible for the background current maintaining the membrane resting potential. TASK-3 is involved in several neurological diseases but recent studies pointed out its oncogenic potential. TASK-3 aberrant expression was detected in breast, lung and colorectal cancer cells.

This research proposal aims at 1) generate antibodies that can directly reduce TASK-3 function.

The potency, the binding mode of the best antibodies will be characterized functionally and structurally to provide an atomic-resolution view of the mechanism of binding, paving the way for antibody engineering.

The structural approach will also produce the three-dimensional structure of TASK-3, which will deepen our understanding on the biophysical properties of this channel and its involvement in several other pathologies. 2) Reduce TASK-3 activity by understanding the molecular basis of its trafficking to the membrane.

The project aims at providing a structural and functional analysis of the complex between TASK-3 and the cation cotrasporter KCC2, a recently identified partner that affect TASK-3 trafficking to the membrane.

Structural information on the complex will uncover regions of the channel involved in binding protein partners, opening the possibility of pursuing these protein-protein interactions surfaces as targets for drug discovery, with the ultimate goal of modulating ion channel activity.

I will undertake a multidisciplinary study that spans protein biochemistry, structural biology, electrophysiology and antibody engineering.

The project tackles side by side - basic science questions (ion channel structure and regulation) and translational research (antibody-based therapy).

It offers a molecular understanding of the structural and biophysical properties of TASK-3 -currently unavailable- and opens the venue to the therapeutic targeting of this ion channel.

All Grantees

Universita Degli Studi Di Pavia

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant